9.94
+0.32
+(3.37%)
As of 8:16:34 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-192,121.00
-194,916.00
-178,142.00
-121,163.00
-74,640.00
Investing Cash Flow
28,772.00
-98,066.00
-69,326.00
18,853.00
-96,591.00
Financing Cash Flow
3,281.00
208,401.00
155,288.00
37,681.00
282,989.00
End Cash Position
66,961.00
57,276.00
141,857.00
234,037.00
298,666.00
Interest Paid Supplemental Data
--
--
--
148.00
2,960.00
Capital Expenditure
-10,200.00
-16,472.00
-8,619.00
-7,715.00
-29,059.00
Issuance of Capital Stock
3,281.00
208,394.00
155,335.00
37,681.00
281,354.00
Repurchase of Capital Stock
--
--
-47.00
--
-72.00
Free Cash Flow
-202,321.00
-211,388.00
-186,761.00
-128,878.00
-103,699.00
12/31/2020 - 3/19/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1U5.F Wave Life Sciences Ltd.
11.40
+2.70%
0K4.BE Akero Therapeutics Inc
53.42
-0.60%
0K4.F Akero Therapeutics, Inc.
54.08
+4.77%
COYA Coya Therapeutics, Inc.
5.86
+0.17%
22UA.DE BioNTech SE
117.70
-0.76%
EDSA Edesa Biotech, Inc.
1.8900
+1.07%
ANIX Anixa Biosciences, Inc.
2.9400
-2.00%
WVE Wave Life Sciences Ltd.
12.06
+1.26%
VTYX Ventyx Biosciences, Inc.
2.0500
+5.67%
SRRK Scholar Rock Holding Corporation
40.40
-5.08%